Chronic Conditions
Hinge Health’s Billion Dollar IPO: Unit Economics in Musculoskeletal Care
The conversation around healthcare AI investing has changed. Forget the aspirational growth stories and the “change…
Chronic Conditions
The conversation around healthcare AI investing has changed. Forget the aspirational growth stories and the “change…
Medical Breakthroughs
For investors looking at cleared cardiac monitoring assets, the path from a regulatory green light to…
Medical Breakthroughs
The data on Butterfly Network is solid, fiscal 2025 revenue hit $97.6 million, a 19% year-over-year…
Medical Breakthroughs
In healthcare AI, the investment game is no longer about who raises the most capital. It’s…
Medical Breakthroughs
Everyone loves to talk about the size of the funding round in healthcare AI, with headlines…
Medical Breakthroughs
The whole conversation around healthcare AI exits has changed. The speculative gold rush is over, and…
Medical Breakthroughs
When a new AI medical device gets FDA clearance, it’s easy to get excited. For investors…
Chronic Conditions
Hinge Health’s public listing in May 2025, right after an $854 million raise, shows how the…
Chronic Conditions
When Omada Health went public on Nasdaq in June 2025 and raised $150 million, family offices…
Medical Breakthroughs
Healthcare AI investing is full of hidden traps. Everyone gets fixated on clinical validation, FDA pathways,…